Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Medicine
FY 2022-23
Summary
Colorectal cancer (CRC) is the third highest cause of cancer deaths worldwide, projected with 24,300 new cases with an estimation of 9400 deaths by the Canadian Cancer Statistics in 2022. The standard-of-care chemotherapy regimens are FOLFOX (Leucovorin (LV) /Fluorouracil (5-FU) /Oxaliplatin) and FOLFIRI (LV/5-FU/CPT-11). While non-metastatic CRC has a highly favorable prognosis with surgery and chemotherapy, metastatic CRC remains incurable due to chemoresistance and relapse in long-term management. One proposed mechanism is CRC cells entering the drug-tolerant persister (DTP) state. CRC cells may initially respond well to chemotherapy but regrow after being given a drug holiday. DTPs could either be drug-induced or by clonal selection, where chemotherapy exposure induces a phenotypic change of CRC cells or selects DTPs under pressure, similar to the concept of antibiotics resistance. Hence, there is an evident need to understand the biologics and improve therapeutics for DTP state CRC. Recently, exosomes or cell-secreted extracellular vesicles, have been shown to play an indispensable role in intracellular communication and is an advantageous therapeutic target. Yet, its role in DTP state initiation and progression has not been well-understood. Multiple studies have revealed that acquired chemoresistance is closely related to microRNA (miRNA) in exosomes, influencing pathways such as drug transporter expressions and DNA damage repair. We hypothesise that miRNAs could play a key functional role in coordinating CRC entry into the DTP state through secreted miRNAs in exosomes. In this study, we aim to identify novel miRNA driving CRC chemoresistance, investigate its functional role in downstream gene expression, and guide the development of miRNA-targeted therapeutics.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
486448
Name
Kwan Ka Yu Carissa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Medicine
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Chemoresistance; Colorectal Cancer; Drug Persisters; Exosomes; Microrna; Single Cell Microrna-Sequencing; Targeted Therapy; Tumor Dormancy
Abstract
Colorectal cancer (CRC) is the third highest cause of cancer deaths worldwide, projected with 24,300 new cases with an estimation of 9400 deaths by the Canadian Cancer Statistics in 2022. The standard-of-care chemotherapy regimens are FOLFOX (Leucovorin (LV) /Fluorouracil (5-FU) /Oxaliplatin) and FOLFIRI (LV/5-FU/CPT-11). While non-metastatic CRC has a highly favorable prognosis with surgery and chemotherapy, metastatic CRC remains incurable due to chemoresistance and relapse in long-term management. One proposed mechanism is CRC cells entering the drug-tolerant persister (DTP) state. CRC cells may initially respond well to chemotherapy but regrow after being given a drug holiday. DTPs could either be drug-induced or by clonal selection, where chemotherapy exposure induces a phenotypic change of CRC cells or selects DTPs under pressure, similar to the concept of antibiotics resistance. Hence, there is an evident need to understand the biologics and improve therapeutics for DTP state CRC. Recently, exosomes or cell-secreted extracellular vesicles, have been shown to play an indispensable role in intracellular communication and is an advantageous therapeutic target. Yet, its role in DTP state initiation and progression has not been well-understood. Multiple studies have revealed that acquired chemoresistance is closely related to microRNA (miRNA) in exosomes, influencing pathways such as drug transporter expressions and DNA damage repair. We hypothesise that miRNAs could play a key functional role in coordinating CRC entry into the DTP state through secreted miRNAs in exosomes. In this study, we aim to identify novel miRNA driving CRC chemoresistance, investigate its functional role in downstream gene expression, and guide the development of miRNA-targeted therapeutics.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kwan, Ka Yu Carissa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~